Phuong Khanh Morrow

Phuong Khanh (PK) Morrow is a seasoned executive in the biotechnology and pharmaceutical sectors, currently serving as Senior Vice President and Head of the Oncology Therapeutic Area Unit at Takeda since January 2024. Previously, Morrow was the Chief Medical Officer at CRISPR Therapeutics, leading a comprehensive team across various disciplines to develop innovative therapies for oncology and other diseases. Morrow's extensive experience at Amgen includes multiple roles, such as Vice President and Therapeutic Area Head of Hematology and Oncology, where oversight encompassed a wide array of hematology and oncology clinical programs. Earlier career highlights include an Assistant Professorship at the University of Texas MD Anderson Cancer Center and academic training in Hematology/Oncology and Medicine from prestigious institutions.